Context: Subclinical thyroid dysfunction is common in older people. However, its clinical importance is uncertain. Objective: Our objective was to determine the extent to which subclinical hyperthyroidism and hypothyroidism influence the risk of heart failure and cardiovascular diseases in older people. Setting and Design: The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) is an prospective cohort study. Patients: Patients included men and women aged 70-82 yr (n = 5316) with known cardiovascular risk factors or previous cardiovascular disease. Main Outcome Measures: Incidence rate of heart failure hospitalization, atrial fibrillation, and cardiovascular events and mortality according to baseline thyroid status were evalua...
CONTEXT: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United ...
Background: The cardiovascular effects of treating older adults with subclinical hypothyroidism (SCH...
The association between subclinical thyroid dysfunction and cardiovascular outcomes has been recentl...
Context: Subclinical thyroid dysfunction is common in older people. However, its clinical importance...
Context:Subclinical thyroid dysfunction is common in older people. However, its clinical importance ...
Objectives: Subclinical hypothyroidism (SCH) is a common disorder that is characterized by elevated ...
OBJECTIVES: The goal of this study was to determine whether subclinical thyroid dysfunction was asso...
Abstract: Context: Although the negative impact of subclinical hypothyroidism (sHT) in terms of card...
The negative impact of subclinical hypothyroidism (sHT) on cardiovascular risk, widely recognized in...
Objective: Thyroid hormones have been implicated to play a role in cardiovascular disease, along wit...
BACKGROUND: Subclinical hypothyroidism has been associated with systolic and diastolic cardiac dysfu...
Background: American College of Cardiology/American Heart Association guidelines for the diagnosis ...
Context: There are limited studies describing mortality and morbidity in patients treated for hypert...
Context: Subclinical hypothyroidism (SCH) is associated with increased risk of cardiac disease; its ...
PURPOSE: Thyroid dysfunction is common, particularly among older women. The safety of thyroid hormon...
CONTEXT: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United ...
Background: The cardiovascular effects of treating older adults with subclinical hypothyroidism (SCH...
The association between subclinical thyroid dysfunction and cardiovascular outcomes has been recentl...
Context: Subclinical thyroid dysfunction is common in older people. However, its clinical importance...
Context:Subclinical thyroid dysfunction is common in older people. However, its clinical importance ...
Objectives: Subclinical hypothyroidism (SCH) is a common disorder that is characterized by elevated ...
OBJECTIVES: The goal of this study was to determine whether subclinical thyroid dysfunction was asso...
Abstract: Context: Although the negative impact of subclinical hypothyroidism (sHT) in terms of card...
The negative impact of subclinical hypothyroidism (sHT) on cardiovascular risk, widely recognized in...
Objective: Thyroid hormones have been implicated to play a role in cardiovascular disease, along wit...
BACKGROUND: Subclinical hypothyroidism has been associated with systolic and diastolic cardiac dysfu...
Background: American College of Cardiology/American Heart Association guidelines for the diagnosis ...
Context: There are limited studies describing mortality and morbidity in patients treated for hypert...
Context: Subclinical hypothyroidism (SCH) is associated with increased risk of cardiac disease; its ...
PURPOSE: Thyroid dysfunction is common, particularly among older women. The safety of thyroid hormon...
CONTEXT: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United ...
Background: The cardiovascular effects of treating older adults with subclinical hypothyroidism (SCH...
The association between subclinical thyroid dysfunction and cardiovascular outcomes has been recentl...